News & Updates
Filter by Specialty:
CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
For patients undergoing surgery for oesophageal and gastric cancer, cardiopulmonary exercise testing (CPET) appears to be a reliable predictor of major cardiovascular complications, as reported in a study.
CPET a useful cardiovascular risk assessment tool for patients undergoing cancer surgery
24 Jul 2022
Sugar-sweetened drinks tied to increased liver cancer risk?
A high intake of sugar-sweetened beverages (SSBs) may be linked to an increased risk of liver cancer, according to an observational study on postmenopausal women presented at Nutrition 2022.
Sugar-sweetened drinks tied to increased liver cancer risk?
24 Jul 2022
Ribociclib–binimetinib combo safe, effective in NRAS-mutant melanoma
Treatment with the combination of ribociclib plus binimetinib appears to be well tolerated and delivers modest clinical activity in patients with locally advanced or metastatic melanoma harbouring NRAS mutation, according to the results of a phase Ib/II study.
Ribociclib–binimetinib combo safe, effective in NRAS-mutant melanoma
22 Jul 2022
Early mortality explains colorectal cancer survival gap between older, young patients
In patients with colorectal cancer (CRC), the survival gap between older and younger patient can largely be attributed to deaths during the first year after resection, a recent study has found.
Early mortality explains colorectal cancer survival gap between older, young patients
20 Jul 2022
Weekly dose-dense CT does not confer survival benefit for ovarian cancer patients
In the final analysis of the phase III ICON8* study, a weekly dose-dense chemotherapy (CT) regimen comprising paclitaxel and carboplatin did not improve survival outcomes in women with epithelial ovarian cancer** compared with the standard first-line (1L) paclitaxel-carboplatin regimen given once every 3 weeks (Q3W).